KANE BIOTECH INC (KNE.CA) Stock Cash Flow
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 6.29M | 6.17M | -5.27M | -3.82M | -4.85M | |||
| Depreciation Amortization | 212.30K | 218.50K | 238.60K | 263.40K | 188.00K | |||
| Income Taxes - Deferred | N/A | -1.31M | 0.00 | N/A | N/A | |||
| Change In Working Capital | -859.70K | -319.70K | 1.72M | 394.50K | 1.65M | |||
| Interest Paid | 796.80K | 961.80K | 258.00K | N/A | N/A | |||
| Other non cash items | -8.57M | -8.87M | 1.23M | 122.70K | 722.50K | |||
| OPERATING CASH FLOW | -4.23M | -4.11M | -2.08M | -3.04M | -2.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -127.70K | -90.10K | -49.70K | -87.60K | -353.50K | |||
| Other Investing Activity | 10.36M | 10.36M | 760.30K | -20.00K | -20.00K | |||
| INVESTING CASH FLOW | 10.23M | 10.27M | 710.60K | -107.60K | -373.60K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.62M | -6.65M | 1.53M | 2.25M | 1.25M | |||
| Stock Issued/Repurchased | N/A | 499.10K | 415.80K | 973.70K | 1.12M | |||
| Other Financing Activity | -2.55M | -1.53M | 211.80K | -120.60K | 445.30K | |||
| FINANCING CASH FLOW | -7.21M | -7.69M | 2.16M | 3.10M | 2.81M | |||
| CHANGE IN CASH | -1.21M | -1.53M | 783.80K | -48.20K | 145.20K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.23M | -4.11M | -2.08M | -3.04M | -2.29M | |||
| Capital Expenditure | -127.70K | -90.10K | -49.70K | -87.60K | -353.50K | |||
| FREE CASH FLOW | -4.36M | -4.20M | -2.13M | -3.13M | -2.64M | |||
All data in CAD